Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Clinical trial NCT02675959 · RECRUITING
Trial details
- NCT number
- NCT02675959
- Sponsor
- New York Medical College
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2026-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.